Skip to content

Delayed or Immediate Local Treatment of Veins

Delayed or Immediate Local Treatment of Varicose Veins

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03340246
Acronym
DELICATVE
Enrollment
140
Registered
2017-11-13
Start date
2016-05-04
Completion date
2022-12-31
Last updated
2022-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose Veins Leg

Keywords

Varicose veins, phlebectomy

Brief summary

Varicose veins affect a majority of adult patients and cause a decreased quality of life. In recent years, standard practice has been to perform thermoablation and local phlebectomies in the same procedure. There is conflicting data on the long-term outcome of the local varicose veins; there seems to be a need for more re-interventions if the local varicosities are not treated immediately. On the other hand, the prolonged combined procedure increases procedural pain and bleeding, as well as the risk for complications from deep vein thrombosis/pulmonary embolism. This trial aims to evaluate the need for immediate treatment of local varicosities and the potential sufficiency of main trunk treatment.

Interventions

PROCEDUREDelayed sclerotherapy

See arm descriptions

PROCEDUREImmediate phlebectomy

See arm description

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Ultrasound verified insufficiency of great saphenous vein (GSV) * GSV diameter 5-10 mm * C2-C4 varicosities * Most proximal insufficient branch in the distal thigh * Written and signed informed consent

Exclusion criteria

* Peripheral arterial disease * Body mass index \>40 * Lymphoedema * Known allergy to sclerosant * Any known coagulopathy or history of deep vein thrombosis * Severe illness * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Need for sclerotherapy3 monthsNeed for sclerotherapy of varicosities at three months after ablation of main trunk. Evaluated by the CEAP-classification of venous insufficiency. \>C2 will be eligible for treatment.

Secondary

MeasureTime frameDescription
Patient satisfaction3 monthsOverall patient satisfaction and symptoms regarding varicosities and procedure at three months. Evaluated by the Aberdeen Varicose Veins Questionnaire (AVVQ). The AVVQ is a validated test, in which patients are asked to check boxes with regard to symptoms and quality of life (QoL). Scale 0-100, with 100 indicating worst possible QoL.
Occlusion rate of great saphenous vein36 monthsLong-term occlusion rate of main trunk after mechanochemical ablation, evaluated by duplex ultrasound.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026